Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Organ Grafts”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT06982404
What this trial is testing

ZeroHeart Biopsy - Prediction of Deceased Donor Heart Transplant Performance From Organ Donors Using Pre-Transplant Biopsies - A Pilot Study

Who this might be right for
Heart TransplantationGraft RejectionMyocardial Injury+3 more
Medical University of Vienna 50
Testing effectiveness (Phase 2)Study completedNCT01614665
What this trial is testing

Compare How the Body Absorbs and Processes Two Different Formulations of the Anti-rejection Medication Tacrolimus (Advagraf® or Prograf®) in Children Receiving an Organ Transplant, and How Safe and Effective They Are Over a Longer Period of Time

Who this might be right for
Heart TransplantationKidney TransplantationLiver Transplantation
Astellas Pharma Europe Ltd. 44
Not applicableUnknownNCT02533245
What this trial is testing

Transplantoux Health Evaluation Study

Who this might be right for
Quality of Life
Universitaire Ziekenhuizen KU Leuven 500
Testing effectiveness (Phase 2)Looking for participantsNCT06909110
What this trial is testing

Viral Specific T-Lymphocytes to Treat Infection With Adenovirus, Cytomegalovirus or Epstein-Barr Virus in Patients With Compromised Immunity

Who this might be right for
AdenovirusCytomegalovirus InfectionsEpstein-Barr Virus Infections
Jessie L. Alexander 25
Not applicableStudy completedNCT05417815
What this trial is testing

Interest of Nitazoxanide Treatment of Enterocytozoon Bieneusi Intestinal Microsporidiosis

Who this might be right for
Microsporidiosis Intestinal
University Hospital, Clermont-Ferrand 80
Large-scale testing (Phase 3)Active Not RecruitingNCT05860881
What this trial is testing

Topical Sirolimus in Chemoprevention of Facial Squamous Cell Carcinomas in Solid Organ Transplant Recipients (SiroSkin)

Who this might be right for
Solid Organ Transplant RecipientsSkin Cancer
Melanoma and Skin Cancer Trials Limited 146
Not applicableUnknownNCT03255265
What this trial is testing

Clinical Study of Microchimerism and cfDNA as Biomarkers for Acute Rejection After Organ Transplantation

Who this might be right for
Organ Transplant Rejection
Fuzhou General Hospital 950
Post-approval studies (Phase 4)Study completedNCT00431353
What this trial is testing

VICTOR Study - A Study of Valcyte (Valganciclovir po) Compared to Ganciclovir iv in Patients With Cytomegalovirus (CMV) Disease Who Are Solid Organ Transplant Recipients

Who this might be right for
Cytomegalovirus Infections
Hoffmann-La Roche 325
Not applicableLooking for participantsNCT01283295
What this trial is testing

Immune Monitoring and Assay Development in Organ Transplant Recipients

Who this might be right for
Organ TransplantationTransplantation Immunology
Emory University 5,000
Large-scale testing (Phase 3)Looking for participantsNCT03394365
What this trial is testing

Tabelecleucel for Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Failure With Rituximab or Rituximab and Chemotherapy

Who this might be right for
Epstein-Barr Virus+ Associated Post-transplant Lymphoproliferative Disease (EBV+ PTLD)Solid Organ Transplant ComplicationsLymphoproliferative Disorders+2 more
Pierre Fabre Medicament
Testing effectiveness (Phase 2)Study completedNCT00204789
What this trial is testing

Difluoromethylornithine (DFMO) Chemoprevention of Skin Cancer in Organ Transplant Recipients

Who this might be right for
Post-solid Organ TransplantSkin Neoplasms
University of Wisconsin, Madison 52
Testing effectiveness (Phase 2)Study completedNCT01329185
What this trial is testing

Treating Kidney Donors With Valganciclovir to Reduce Viral Transmission to Recipients

Who this might be right for
EBV ViremiaCMV Viremia
University of Minnesota 17
Not applicableStudy completedNCT05116748
What this trial is testing

COVID19 Vaccine in SOT Adult Recipients

Who this might be right for
COVID-19Vaccine Adverse ReactionVaccine Response Impaired+4 more
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico 364
Not applicableStudy completedNCT00817908
What this trial is testing

Quantiferon - Cytomegalovirus (CMV) and the Prediction of CMV Infection In High Risk Solid Organ Transplant Recipients

Who this might be right for
Cytomegalovirus Infection
University of Alberta 131
Not applicableLooking for participantsNCT05732779
What this trial is testing

Mobile Video Directly Observed Therapy (DOT) for Immunosuppression Medication Adherence in Adolescent Heart Transplant Recipients

Who this might be right for
Heart Transplant RejectionImmune SuppressionPediatric Heart Transplant+4 more
University of Florida 100
Not applicableStudy completedNCT07394660
What this trial is testing

The Effect of Remote Reiki Treatment on Hopelessness, Fatigue and Pain in Patients Awaiting Organ Transplantation

Who this might be right for
Organ or Tissue Transplant; ComplicationsReiki
Bozok University 30
Post-approval studies (Phase 4)Looking for participantsNCT06958796
What this trial is testing

Strategic Help With Immunoglobulin to Enhance Protect Against Late Disease (CMV)

Who this might be right for
CytomegalovirusOrgan TransplantKidney Transplant; Complications+2 more
Camille N. Kotton, MD 80
Not applicableStudy completedNCT02676102
What this trial is testing

RCT Comparing Tailored Versus Targeted Organ Donation Video Education

Who this might be right for
Organ Transplants
NYU Langone Health 1,440
Large-scale testing (Phase 3)Looking for participantsNCT05319353
What this trial is testing

Evaluate the Safety and Tolerability, Pharmacokinetics, and Antiviral Activity of Maribavir for the Treatment of Cytomegalovirus (CMV) Infection in Children and Adolescents Who Have Received a Hematopoietic Stem Cell Transplant (HSCT) or a Solid Organ Transplant (SOT)

Who this might be right for
Cytomegalovirus (CMV)
Takeda 80
Not applicableUnknownNCT02469207
What this trial is testing

Regenerative Cellular Therapies, Physiology, Pathology and Developmental Biology

Who this might be right for
Graft RejectionTransplantationDiabetes Mellitus
Cambridge University Hospitals NHS Foundation Trust 50
Next Page
115